BSXBoston Scientific Corporation

$103B

FY 2014 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.4B+3.3% YoY

Gross Profit

$4.6B62.2% margin

Operating Income

$845M11.4% margin

Net Income

-$119M-1.6% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.0B

Stock-Based Comp.

$103M

Balance Sheet

Total Assets

$16.8B

Total Liabilities

$10.0B

Stockholders' Equity

$6.8B

Cash & Equivalents

$587M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.4B	$7.1B	+3.3%
Gross Profit	$4.6B	$4.5B	+1.2%
Operating Income	$845M	$871M	-3.0%
Net Income	-$119M	-$121M	+1.7%

BSX FY 2014 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena